Exchange: NASDAQ·Updated 07:34 PM EDT
SOPH logo

SOPHSOPHiA Genetics SA

$5.72
$0.33
(5.46%)
Today
Closed $5.72
$0.0534
(0.93%)
After Hours
EarningsAug 4
Mkt Cap$479.88M
Vol192,984.00
News
all
press releases
Tempus AI Stock Before Q2 Earnings Release: To Buy, Hold or Sell?
TEM heads into Q2 earnings with 21.3% expected revenue growth, strong diagnostics demand and AI deals, but near-term margin pressure remains.
Zacks
More News
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 PR Newswire BOSTON and ROLLE, Switzerland, July 21, 2026 BOSTON and ROLLE, Switzerland, July 21, 2026 /PRNewswire...
PR Newswire
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting PR Newswire ROLLE, Switzerland, June 22, 2026 Shareholders adopt all proposals, co-founder Dr. Jurgi Camblong elected as Executive Chairman of the Board, Ross...
PR Newswire
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to...
PR Newswire
CarMax, Jabil And 3 Stocks To Watch Heading Into Wednesday
U.S. stock futures trading higher. CarMax, Sophia Genetics, Jabil, La-Z-Boy, and Safe Bulkers in focus. La-Z-Boy shares jump 17.7% after earnings.read more...
Benzinga
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares PR Newswire BOSTON and ROLLE, Switzerland, June 16, 2026 BOSTON and ROLLE, Switzerland, June 16, 2026 /PRNewswire/ -- SOPHiA...
PR Newswire
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares PR Newswire BOSTON and ROLLE, Switzerland, June 16, 2026 BOSTONand ROLLE,Switzerland, June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global...
PR Newswire
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting PR Newswire BOSTON and ROLLE, Switzerland, June 10, 2026 Ross Muken to assume the role of Chief Executive Officer effective July 1...
PR Newswire
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center PR Newswire NEW YORK, June 4, 2026 SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine...
PR Newswire
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.